Pages with the most revisions

From IDWiki

Showing below up to 500 results in range #501 to #1,000.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Open joint injury‏‎ (5 revisions)
  2. Ornithodorus‏‎ (5 revisions)
  3. Adult-onset Still's disease‏‎ (5 revisions)
  4. Pancreatitis‏‎ (5 revisions)
  5. Chronic myeloid leukemia‏‎ (5 revisions)
  6. Cladophialophora‏‎ (5 revisions)
  7. Implantable cardiac electric device (ICED/CIED) infections‏‎ (5 revisions)
  8. Bacterial vaginosis‏‎ (5 revisions)
  9. Native vertebral osteomyelitis (IDSA 2015)‏‎ (5 revisions)
  10. Cutaneous tuberculosis‏‎ (5 revisions)
  11. Pseudomonas‏‎ (5 revisions)
  12. Acute necrotizing encephalopathy‏‎ (5 revisions)
  13. Tigecycline‏‎ (5 revisions)
  14. Microbacterium‏‎ (5 revisions)
  15. Peritoneal dialysis-associated peritonitis‏‎ (5 revisions)
  16. Opioid pain medications‏‎ (5 revisions)
  17. HIV-tuberculosis coinfection‏‎ (5 revisions)
  18. Campylobacter coli‏‎ (5 revisions)
  19. Oseltamivir‏‎ (5 revisions)
  20. Rhizopus‏‎ (5 revisions)
  21. Ventriculitis‏‎ (5 revisions)
  22. Multidrug-resistant Gram-negative bacteria‏‎ (5 revisions)
  23. Fever and petechiae‏‎ (5 revisions)
  24. Wound care‏‎ (5 revisions)
  25. Mycobacterium chimaera‏‎ (5 revisions)
  26. Spontaneous gram-negative meningitis‏‎ (5 revisions)
  27. Thrombotic microangiopathy‏‎ (5 revisions)
  28. Lumbar puncture‏‎ (5 revisions)
  29. Urine drug testing‏‎ (5 revisions)
  30. Peritonitis‏‎ (5 revisions)
  31. Streptococcus mitis‏‎ (5 revisions)
  32. Campylobacter ureolyticus‏‎ (5 revisions)
  33. Osler's triad‏‎ (5 revisions)
  34. Isavuconazole‏‎ (5 revisions)
  35. Dientamoeba fragilis‏‎ (5 revisions)
  36. Tocilizumab‏‎ (5 revisions)
  37. Hand hygiene‏‎ (5 revisions)
  38. Congenital parvovirus‏‎ (5 revisions)
  39. Flucytosine‏‎ (5 revisions)
  40. Cystic fibrosis‏‎ (5 revisions)
  41. Psoas abscess‏‎ (5 revisions)
  42. Hantavirus‏‎ (5 revisions)
  43. Revised Clinical Institute Withdrawal Assessment for alcohol‏‎ (5 revisions)
  44. Hepatitis E virus‏‎ (5 revisions)
  45. Chronic Lyme disease‏‎ (5 revisions)
  46. Vascular graft infection‏‎ (5 revisions)
  47. Neisseria‏‎ (5 revisions)
  48. Non-gonococcal urethritis‏‎ (5 revisions)
  49. Grover disease‏‎ (5 revisions)
  50. Acute heart failure‏‎ (5 revisions)
  51. Vasculitis‏‎ (5 revisions)
  52. Severe combined immunodeficiency‏‎ (5 revisions)
  53. Guillain-Barré syndrome‏‎ (5 revisions)
  54. CNS infections in HIV patients‏‎ (5 revisions)
  55. Cannabis use disorder‏‎ (5 revisions)
  56. Rhabdomyolysis‏‎ (5 revisions)
  57. Fungal brain abscesses‏‎ (4 revisions)
  58. Biofilm‏‎ (4 revisions)
  59. Genitourinary tuberculosis‏‎ (4 revisions)
  60. Delirium‏‎ (4 revisions)
  61. Syphilis in pregnancy‏‎ (4 revisions)
  62. Klebsiella granulomatis‏‎ (4 revisions)
  63. COVID-19-associated pulmonary aspergillosis‏‎ (4 revisions)
  64. Cat bite‏‎ (4 revisions)
  65. Hemophagocytic lymphohistiocytosis‏‎ (4 revisions)
  66. Exserohilum‏‎ (4 revisions)
  67. Yersinia‏‎ (4 revisions)
  68. Bartonella quintana‏‎ (4 revisions)
  69. Fungal endocarditis‏‎ (4 revisions)
  70. Bony metastases‏‎ (4 revisions)
  71. Gut microbiota‏‎ (4 revisions)
  72. Oral candidiasis‏‎ (4 revisions)
  73. Albendazole‏‎ (4 revisions)
  74. Lymphadenopathy‏‎ (4 revisions)
  75. Shelters in Hamilton‏‎ (4 revisions)
  76. Waterhouse-Friderichsen syndrome‏‎ (4 revisions)
  77. Pleural effusion‏‎ (4 revisions)
  78. Lead toxicity‏‎ (4 revisions)
  79. Discharge summary‏‎ (4 revisions)
  80. Anemia‏‎ (4 revisions)
  81. Aortitis‏‎ (4 revisions)
  82. Common variable immunodeficiency‏‎ (4 revisions)
  83. Dementia‏‎ (4 revisions)
  84. Disseminated intravascular coagulation‏‎ (4 revisions)
  85. Leukemia‏‎ (4 revisions)
  86. HSV in pregnancy‏‎ (4 revisions)
  87. Paenibacillus‏‎ (4 revisions)
  88. Cirrhosis‏‎ (4 revisions)
  89. Yogurt‏‎ (4 revisions)
  90. Nirmatrelvir-ritonavir‏‎ (4 revisions)
  91. Leukemoid reaction‏‎ (4 revisions)
  92. Eggerthella lenta‏‎ (4 revisions)
  93. Exudative throat lesions‏‎ (4 revisions)
  94. Bacteria‏‎ (4 revisions)
  95. Bedaquiline‏‎ (4 revisions)
  96. Nakaseomyces glabrata‏‎ (4 revisions)
  97. Interstitial lung disease‏‎ (4 revisions)
  98. Black yeasts‏‎ (4 revisions)
  99. Hepatic tuberculosis‏‎ (4 revisions)
  100. Central line infection‏‎ (4 revisions)
  101. Upper gastrointestinal bleed‏‎ (4 revisions)
  102. Mycobacterium‏‎ (4 revisions)
  103. Hospital-acquired aspergillosis‏‎ (4 revisions)
  104. Chronic meningitis‏‎ (4 revisions)
  105. Ventilator-associated pneumonia‏‎ (4 revisions)
  106. Piperacillin-tazobactam‏‎ (4 revisions)
  107. Lacazia loboi‏‎ (4 revisions)
  108. Lower leg ulcer‏‎ (4 revisions)
  109. Rhipicephalus sanguineus‏‎ (4 revisions)
  110. Tuberculoma‏‎ (4 revisions)
  111. Mucor‏‎ (4 revisions)
  112. Intestinal spirochetosis‏‎ (4 revisions)
  113. Glossina‏‎ (4 revisions)
  114. Bronchiectasis‏‎ (4 revisions)
  115. Dermacentor andersoni‏‎ (4 revisions)
  116. Haemophilus influenzae‏‎ (4 revisions)
  117. Respiratory infection in an immunocompromised person‏‎ (4 revisions)
  118. Rhizomucor‏‎ (4 revisions)
  119. Tuberculosis in HIV patients‏‎ (4 revisions)
  120. Enterobacterales‏‎ (4 revisions)
  121. Meningitis‏‎ (4 revisions)
  122. Arcanobacterium haemolyticum‏‎ (4 revisions)
  123. FIB-4‏‎ (4 revisions)
  124. Virology‏‎ (4 revisions)
  125. Fever and headache‏‎ (4 revisions)
  126. Finegoldia magna‏‎ (4 revisions)
  127. Pre-transplant screening‏‎ (4 revisions)
  128. Daratumumab‏‎ (4 revisions)
  129. AST:platelet ratio index‏‎ (4 revisions)
  130. Acute coronary syndrome‏‎ (4 revisions)
  131. Acute promyelocytic leukemia‏‎ (4 revisions)
  132. How to do an HIV consult‏‎ (4 revisions)
  133. Chronic obstructive pulmonary disease‏‎ (4 revisions)
  134. Perioperative assessment‏‎ (4 revisions)
  135. Hypersensitivity reaction‏‎ (4 revisions)
  136. Siderophilic organisms‏‎ (4 revisions)
  137. Poliovirus‏‎ (4 revisions)
  138. Infections associated with cows‏‎ (4 revisions)
  139. Cryptococcus (IDSA 2010)‏‎ (4 revisions)
  140. Nutritionally variant streptococci‏‎ (4 revisions)
  141. Raoultella‏‎ (4 revisions)
  142. Acute respiratory distress syndrome‏‎ (4 revisions)
  143. Cestodes‏‎ (4 revisions)
  144. Parkinson disease‏‎ (4 revisions)
  145. Chronic osteomyelitis‏‎ (4 revisions)
  146. Atovaquone‏‎ (4 revisions)
  147. Visceral larva migrans‏‎ (4 revisions)
  148. Blood culture contamination‏‎ (4 revisions)
  149. Granulomatous disease‏‎ (4 revisions)
  150. Visible worms‏‎ (4 revisions)
  151. Infections associated with fresh water exposure‏‎ (4 revisions)
  152. Kawasaki disease‏‎ (4 revisions)
  153. Bunyavirales‏‎ (4 revisions)
  154. Pyelonephritis‏‎ (4 revisions)
  155. Acute flaccid paralysis‏‎ (4 revisions)
  156. Ceftazidime-avibactam‏‎ (4 revisions)
  157. Antibiotic-associated diarrhea‏‎ (4 revisions)
  158. von Willebrand Factor disease‏‎ (4 revisions)
  159. Post-transplant acute limbic encephalitis‏‎ (4 revisions)
  160. Keratitis‏‎ (4 revisions)
  161. Tenosynovitis‏‎ (4 revisions)
  162. Rapidly progressing dementia‏‎ (4 revisions)
  163. Opioids‏‎ (4 revisions)
  164. Saccharomyces cerevisiae‏‎ (4 revisions)
  165. Erwinia‏‎ (4 revisions)
  166. Mononucleosis-like illness‏‎ (4 revisions)
  167. Falls in the elderly‏‎ (4 revisions)
  168. Infections associated with immunosuppressants‏‎ (4 revisions)
  169. Inflammatory bowel disease‏‎ (4 revisions)
  170. Neurosurgical infections‏‎ (4 revisions)
  171. Genital ulcer disease‏‎ (4 revisions)
  172. Acinetobacter ursingii‏‎ (4 revisions)
  173. Listeria‏‎ (4 revisions)
  174. Tumour necrosis factor-α inhibitors‏‎ (4 revisions)
  175. Sacral osteomyelitis‏‎ (4 revisions)
  176. Infections associated with malignancy‏‎ (4 revisions)
  177. γ-glutamyltransferase‏‎ (4 revisions)
  178. Cystic fibrosis pulmonary exacerbation‏‎ (4 revisions)
  179. Neutropenia‏‎ (4 revisions)
  180. Detecting antimicrobial resistance‏‎ (4 revisions)
  181. Optochin sensitivity test‏‎ (4 revisions)
  182. Chronic bacterial prostatitis‏‎ (4 revisions)
  183. Incubation period for febrile illnesses‏‎ (4 revisions)
  184. Yellow fever virus‏‎ (4 revisions)
  185. Staphylococcus‏‎ (4 revisions)
  186. Intravenous immune globulin‏‎ (3 revisions)
  187. Subarachnoid hemorrhage‏‎ (3 revisions)
  188. Neutropenic enterocolitis‏‎ (3 revisions)
  189. Ivabradine‏‎ (3 revisions)
  190. Obstructive sleep apnoea‏‎ (3 revisions)
  191. Tick-borne encephalitis virus‏‎ (3 revisions)
  192. Letermovir‏‎ (3 revisions)
  193. Rheumatic heart disease‏‎ (3 revisions)
  194. Lymphadenitis in children‏‎ (3 revisions)
  195. Paragonimus westermani‏‎ (3 revisions)
  196. Vector-borne infections‏‎ (3 revisions)
  197. Fasciola‏‎ (3 revisions)
  198. Indefinite antimicrobial therapy‏‎ (3 revisions)
  199. Infections associated with pigs‏‎ (3 revisions)
  200. Cotton fever‏‎ (3 revisions)
  201. Staphylococcus-associated glomerulonephritis‏‎ (3 revisions)
  202. Posttransplant lymphoproliferative disease‏‎ (3 revisions)
  203. Culture-negative endocarditis‏‎ (3 revisions)
  204. Primary adrenal insufficiency‏‎ (3 revisions)
  205. Systemic lupus erythematosus‏‎ (3 revisions)
  206. Acute intermittent porphyria‏‎ (3 revisions)
  207. Reactive arthritis‏‎ (3 revisions)
  208. Transverse myelitis‏‎ (3 revisions)
  209. Hemoptysis‏‎ (3 revisions)
  210. Tunnel infection‏‎ (3 revisions)
  211. Erythroderma‏‎ (3 revisions)
  212. Polysubstance use disorder‏‎ (3 revisions)
  213. Primary aldosteronism‏‎ (3 revisions)
  214. Subdural hemorrhage‏‎ (3 revisions)
  215. Proton pump inhibitor‏‎ (3 revisions)
  216. Pachymeningeal enhancement‏‎ (3 revisions)
  217. Chimeric antigen receptor T-cell therapy‏‎ (3 revisions)
  218. Type 2 diabetes mellitus‏‎ (3 revisions)
  219. Rothia‏‎ (3 revisions)
  220. Eosinophilic gastroenteritis‏‎ (3 revisions)
  221. Erythromelalgia‏‎ (3 revisions)
  222. Vibrionaceae‏‎ (3 revisions)
  223. Morganella morganii‏‎ (3 revisions)
  224. Aureobasidium pullulans‏‎ (3 revisions)
  225. Splenic granuloma‏‎ (3 revisions)
  226. Interferon-gamma release assay‏‎ (3 revisions)
  227. Gardnerella vaginalis‏‎ (3 revisions)
  228. AIDS-defining illnesses‏‎ (3 revisions)
  229. Giant cell arteritis‏‎ (3 revisions)
  230. Quinine‏‎ (3 revisions)
  231. Leeches‏‎ (3 revisions)
  232. Treatment as prevention for HIV‏‎ (3 revisions)
  233. Perioperative venous thromboembolism prophylaxis‏‎ (3 revisions)
  234. Mitral regurgitation‏‎ (3 revisions)
  235. Pichia kudriavzevii‏‎ (3 revisions)
  236. Pleuritic chest pain‏‎ (3 revisions)
  237. Fibromuscular dysplasia‏‎ (3 revisions)
  238. Crohn disease‏‎ (3 revisions)
  239. Substance use disorder‏‎ (3 revisions)
  240. Actinotignum schaalii‏‎ (3 revisions)
  241. Adalimumab‏‎ (3 revisions)
  242. Lymphocutaneous cellulitis‏‎ (3 revisions)
  243. Amblyomma maculatum‏‎ (3 revisions)
  244. Paraneoplastic retinopathy‏‎ (3 revisions)
  245. Entamoeba‏‎ (3 revisions)
  246. Valganciclovir‏‎ (3 revisions)
  247. Asthma‏‎ (3 revisions)
  248. Infection in long-term care residents‏‎ (3 revisions)
  249. Splenomegaly‏‎ (3 revisions)
  250. Mycoplasma genitalium‏‎ (3 revisions)
  251. Nitazoxanide‏‎ (3 revisions)
  252. Tachysystole‏‎ (3 revisions)
  253. Odynophagia and dysphagia in HIV‏‎ (3 revisions)
  254. Oritavancin‏‎ (3 revisions)
  255. Cavitary lung disease‏‎ (3 revisions)
  256. Pain at the end of life‏‎ (3 revisions)
  257. Antimicrobial abbreviations‏‎ (3 revisions)
  258. Chronic lymphocytic leukemia‏‎ (3 revisions)
  259. Sappinia diploidea‏‎ (3 revisions)
  260. Hypereosinophilic syndrome‏‎ (3 revisions)
  261. Asthma-COPD overlap syndrome‏‎ (3 revisions)
  262. Pigmented bacteria‏‎ (3 revisions)
  263. Wernicke encephalopathy‏‎ (3 revisions)
  264. Slow-release oral morphine‏‎ (3 revisions)
  265. Interstitial nephritis‏‎ (3 revisions)
  266. Japanese encephalitis virus‏‎ (3 revisions)
  267. Ticks‏‎ (3 revisions)
  268. Ornithodoros‏‎ (3 revisions)
  269. Drug-induced neutropenia‏‎ (3 revisions)
  270. Alcohol use disorder‏‎ (3 revisions)
  271. Hepatitis‏‎ (3 revisions)
  272. Elevated cholestatic liver enzymes‏‎ (3 revisions)
  273. Cephalosporins‏‎ (3 revisions)
  274. Hereditary hemorrhagic telangiectasia‏‎ (3 revisions)
  275. Anion gap metabolic acidosis‏‎ (3 revisions)
  276. Micafungin‏‎ (3 revisions)
  277. Approach to Clinical Syndromes: Part I‏‎ (3 revisions)
  278. Confusion assessment method‏‎ (3 revisions)
  279. Cryofibrinogenemia‏‎ (3 revisions)
  280. Praziquantel‏‎ (3 revisions)
  281. Fusarium solani‏‎ (3 revisions)
  282. Blastocystis hominis‏‎ (3 revisions)
  283. Sulfadiazine‏‎ (3 revisions)
  284. Pseudomembranous colitis‏‎ (3 revisions)
  285. Glomerulonephritis‏‎ (3 revisions)
  286. Taenia‏‎ (3 revisions)
  287. Diabetic neuropathy‏‎ (3 revisions)
  288. Dog bite‏‎ (3 revisions)
  289. Calvarial lesion‏‎ (3 revisions)
  290. Lymphoplasmacytic lymphoma‏‎ (3 revisions)
  291. Anisakidosis‏‎ (3 revisions)
  292. Sarcoidosis‏‎ (3 revisions)
  293. Microangiopathic hemolytic anemia‏‎ (3 revisions)
  294. Ethambutol‏‎ (3 revisions)
  295. Ventricular shunt infection‏‎ (3 revisions)
  296. Idiopathic pulmonary fibrosis‏‎ (3 revisions)
  297. Fever‏‎ (3 revisions)
  298. Finegoldia‏‎ (3 revisions)
  299. Gram-variable bacteria‏‎ (3 revisions)
  300. Thrombocytosis‏‎ (3 revisions)
  301. Raillietina‏‎ (3 revisions)
  302. Lytic bone lesion‏‎ (3 revisions)
  303. Cerebrospinal fluid leak‏‎ (3 revisions)
  304. Parasitic brain infections‏‎ (3 revisions)
  305. Hospital-acquired influenza‏‎ (3 revisions)
  306. Antimicrobials in pregnancy‏‎ (3 revisions)
  307. Sepsis‏‎ (3 revisions)
  308. Coronary artery disease‏‎ (3 revisions)
  309. Bell palsy‏‎ (3 revisions)
  310. Dermacentor variabilis‏‎ (3 revisions)
  311. Adverse event‏‎ (3 revisions)
  312. Cefiderocol‏‎ (3 revisions)
  313. Löffler syndrome‏‎ (3 revisions)
  314. Rilonacept‏‎ (3 revisions)
  315. Herpes simplex pneumonitis‏‎ (3 revisions)
  316. Pediculus humanus humanus‏‎ (3 revisions)
  317. Clinical Pulmonary Infection Score‏‎ (3 revisions)
  318. Inadvertent breast milk exposure‏‎ (3 revisions)
  319. Flaviviridae‏‎ (3 revisions)
  320. Corticosteroids‏‎ (3 revisions)
  321. Benzodiazepine use disorder‏‎ (3 revisions)
  322. Streptococcus dysgalactiae subspecies equisimilis‏‎ (3 revisions)
  323. Purpura fulminans‏‎ (3 revisions)
  324. Granulomatous amoebic encephalitis‏‎ (3 revisions)
  325. CR:PMID:32040709‏‎ (3 revisions)
  326. Lemierre syndrome‏‎ (3 revisions)
  327. Lichtheimia‏‎ (3 revisions)
  328. Eastern equine encephalitis virus‏‎ (3 revisions)
  329. Encapsulated bacteria‏‎ (3 revisions)
  330. Chromagar‏‎ (3 revisions)
  331. Scarlet fever‏‎ (3 revisions)
  332. Clinical frailty scale‏‎ (3 revisions)
  333. Multidrug-resistant organism‏‎ (3 revisions)
  334. Congenital Zika‏‎ (3 revisions)
  335. General principles of mycology‏‎ (3 revisions)
  336. Borrelia turicatae‏‎ (3 revisions)
  337. Taxonomy of microorganisms‏‎ (3 revisions)
  338. Purulent pericarditis‏‎ (3 revisions)
  339. ONPG‏‎ (3 revisions)
  340. Acute exacerbation of COPD‏‎ (3 revisions)
  341. Tobramycin‏‎ (3 revisions)
  342. Relapsing polychondritis‏‎ (3 revisions)
  343. Aerococcus sanguinicola‏‎ (3 revisions)
  344. Ceftaroline‏‎ (3 revisions)
  345. Parkinson syndrome‏‎ (3 revisions)
  346. Hypertension in pregnancy‏‎ (3 revisions)
  347. Molluscum contagiosum virus‏‎ (3 revisions)
  348. Imipenem-relebactam‏‎ (3 revisions)
  349. Atovaquone-proguanil‏‎ (3 revisions)
  350. Simulium‏‎ (3 revisions)
  351. Azacitidine‏‎ (3 revisions)
  352. Preeclampsia‏‎ (3 revisions)
  353. Bortezomib‏‎ (3 revisions)
  354. Obesity‏‎ (3 revisions)
  355. Rapid plasma reagin‏‎ (3 revisions)
  356. Opioid withdrawal‏‎ (3 revisions)
  357. Canadian Transient Ischemic Attack Score‏‎ (3 revisions)
  358. Relative bradycardia‏‎ (3 revisions)
  359. Linezolid‏‎ (3 revisions)
  360. Trichomonas vaginalis‏‎ (3 revisions)
  361. Tumor necrosis factor receptor-associated periodic syndrome‏‎ (3 revisions)
  362. Meralgia paresthetica‏‎ (3 revisions)
  363. Chronic sinusitis‏‎ (3 revisions)
  364. Schaalia‏‎ (3 revisions)
  365. Serotonin syndrome‏‎ (3 revisions)
  366. Cryptosporidium parvum‏‎ (3 revisions)
  367. Intrauterine fetal demise‏‎ (3 revisions)
  368. Gout‏‎ (3 revisions)
  369. Pyoderma gangrenosum‏‎ (3 revisions)
  370. HIV prevention‏‎ (3 revisions)
  371. Lung cancer‏‎ (3 revisions)
  372. Hematuria‏‎ (3 revisions)
  373. Uveitis‏‎ (3 revisions)
  374. Immune-mediated thrombocytopenic purpura‏‎ (3 revisions)
  375. Post-transplant renal failure‏‎ (3 revisions)
  376. Bile esculin agar‏‎ (3 revisions)
  377. Crystalloid fluids‏‎ (3 revisions)
  378. Cystic fibrosis antibiotic dosing‏‎ (3 revisions)
  379. Pulmonary-renal syndrome‏‎ (3 revisions)
  380. Terbinafine‏‎ (3 revisions)
  381. Rasamsonia‏‎ (3 revisions)
  382. Leptotrichia‏‎ (3 revisions)
  383. Maculopapular rash‏‎ (3 revisions)
  384. Pembrolizumab‏‎ (3 revisions)
  385. Schnitzler syndrome‏‎ (3 revisions)
  386. Perioperative management of cardiac ischemia‏‎ (3 revisions)
  387. Hyperthyroidism‏‎ (3 revisions)
  388. Familial Mediterranean fever‏‎ (3 revisions)
  389. Corynebacterium pseudotuberculosis‏‎ (3 revisions)
  390. Staphylococcal toxic shock syndrome‏‎ (3 revisions)
  391. Gram-negative bacteremia‏‎ (3 revisions)
  392. Acute stroke‏‎ (3 revisions)
  393. Osteomyelitis with orthopedic hardware‏‎ (3 revisions)
  394. Caspofungin‏‎ (3 revisions)
  395. Roseomonas‏‎ (3 revisions)
  396. Pemphigoid gestationis‏‎ (3 revisions)
  397. Erythema multiforme‏‎ (3 revisions)
  398. Fever in an HIV patient‏‎ (3 revisions)
  399. Corynebacterium striatum‏‎ (3 revisions)
  400. ​ASA Physical Status Classification System‏‎ (3 revisions)
  401. NEC‏‎ (2 revisions)
  402. Influenza virus‏‎ (2 revisions)
  403. Prevotella‏‎ (2 revisions)
  404. Abatacept‏‎ (2 revisions)
  405. Pulmonary emphysema‏‎ (2 revisions)
  406. Non-stress test‏‎ (2 revisions)
  407. Pyrazinamide‏‎ (2 revisions)
  408. Lassa virus‏‎ (2 revisions)
  409. Guillian-Barré syndrome‏‎ (2 revisions)
  410. Oral bioavailability of antimicrobials‏‎ (2 revisions)
  411. HLA-B27‏‎ (2 revisions)
  412. Drive + Fly‏‎ (2 revisions)
  413. Acute toxic leukoencephalopathy‏‎ (2 revisions)
  414. Renal calculi‏‎ (2 revisions)
  415. Agrobacterium‏‎ (2 revisions)
  416. Transient ischemic attack and minor stroke‏‎ (2 revisions)
  417. PREDICT score‏‎ (2 revisions)
  418. Ectopic pregnancy‏‎ (2 revisions)
  419. Anaphylaxis‏‎ (2 revisions)
  420. Tungiasis‏‎ (2 revisions)
  421. Antibiotics in sodium restriction‏‎ (2 revisions)
  422. Vaccine-induced immune thrombotic thrombocytopenia‏‎ (2 revisions)
  423. Saint Louis encephalitis virus‏‎ (2 revisions)
  424. Hyper-IgE syndrome‏‎ (2 revisions)
  425. CR:DOI:6cc99a5f77a6e9655d861ca2d1fc3c25‏‎ (2 revisions)
  426. Erythema nodosum‏‎ (2 revisions)
  427. Scombroid‏‎ (2 revisions)
  428. Phlegmasia cerulea dolens‏‎ (2 revisions)
  429. Atypical pneumonia‏‎ (2 revisions)
  430. Colitis‏‎ (2 revisions)
  431. Skull base‏‎ (2 revisions)
  432. Plesiomonas shigelloides‏‎ (2 revisions)
  433. Congenital varicella‏‎ (2 revisions)
  434. Galactorrhea‏‎ (2 revisions)
  435. (1,3)-β-D-glucan‏‎ (2 revisions)
  436. Subdural empyema‏‎ (2 revisions)
  437. Neutrophilia‏‎ (2 revisions)
  438. Pulmonary function tests‏‎ (2 revisions)
  439. Diabetes in pregnancy‏‎ (2 revisions)
  440. Thalassemia‏‎ (2 revisions)
  441. Ochrobactrum‏‎ (2 revisions)
  442. Osteoporosis‏‎ (2 revisions)
  443. Hartford nomogram‏‎ (2 revisions)
  444. Rheumatoid arthritis‏‎ (2 revisions)
  445. Paralytic shellfish poisoning‏‎ (2 revisions)
  446. Hepatopulmonary syndrome‏‎ (2 revisions)
  447. Pasteurella multocida‏‎ (2 revisions)
  448. Chronic fatigue syndrome‏‎ (2 revisions)
  449. Salicylate-ASA toxicity‏‎ (2 revisions)
  450. Methanol toxicity‏‎ (2 revisions)
  451. Aortic stenosis‏‎ (2 revisions)
  452. Aspergillus oryzae‏‎ (2 revisions)
  453. Clostridium chauvoei‏‎ (2 revisions)
  454. Immunization after hematopoietic stem cell transplantation‏‎ (2 revisions)
  455. Fasciola hepatica‏‎ (2 revisions)
  456. CR:DOI:a55f83309a6e6f4ddbc632334a718bda‏‎ (2 revisions)
  457. Conjunctivitis‏‎ (2 revisions)
  458. Mycobacterium ulcerans‏‎ (2 revisions)
  459. Infections associated with rabbits‏‎ (2 revisions)
  460. NYHA classes‏‎ (2 revisions)
  461. Intrinsic vancomycin resistance‏‎ (2 revisions)
  462. Nevirapine‏‎ (2 revisions)
  463. Ixekizumab‏‎ (2 revisions)
  464. Germ tube test‏‎ (2 revisions)
  465. Pulmonary hypertension‏‎ (2 revisions)
  466. Klebsiella variicola‏‎ (2 revisions)
  467. Gram-negative diplococci‏‎ (2 revisions)
  468. Burning mouth syndrome‏‎ (2 revisions)
  469. Diabetes insipidus‏‎ (2 revisions)
  470. Pyrrolidonyl arylamidase test‏‎ (2 revisions)
  471. Gynecomastia‏‎ (2 revisions)
  472. Calcium channel blocker toxicity‏‎ (2 revisions)
  473. Leuconostoc mesenteroides‏‎ (2 revisions)
  474. Acute urinary retention‏‎ (2 revisions)
  475. Capnocytophaga canimorsus‏‎ (2 revisions)
  476. Liver disease in HIV‏‎ (2 revisions)
  477. Head and neck cancers‏‎ (2 revisions)
  478. Catamenial epilepsy‏‎ (2 revisions)
  479. Lymphadenopathy in children‏‎ (2 revisions)
  480. Hemorrhage‏‎ (2 revisions)
  481. Edwards' syndrome‏‎ (2 revisions)
  482. Alzheimer disease‏‎ (2 revisions)
  483. Mallampati score‏‎ (2 revisions)
  484. Hepatorenal syndrome‏‎ (2 revisions)
  485. Patau syndrome‏‎ (2 revisions)
  486. Antiepileptic drugs‏‎ (2 revisions)
  487. Vaginal discharge‏‎ (2 revisions)
  488. Methemoglobinemia‏‎ (2 revisions)
  489. Hypercalcemia‏‎ (2 revisions)
  490. Aspergillus sojae‏‎ (2 revisions)
  491. Weissella‏‎ (2 revisions)
  492. Pleural effusion in allogeneic hematopoietic stem cell transplantation‏‎ (2 revisions)
  493. Infection-associated glomerulonephritis‏‎ (2 revisions)
  494. Mycology lab safety‏‎ (2 revisions)
  495. Infections associated with racoons‏‎ (2 revisions)
  496. Cunninghamella bertholletiae‏‎ (2 revisions)
  497. Nicotine withdrawal‏‎ (2 revisions)
  498. Brentuximab vedotin‏‎ (2 revisions)
  499. Sézary syndrome‏‎ (2 revisions)
  500. Non-typhoidal Salmonella vascular infection score‏‎ (2 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)